NEW HYDE PARK, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- CareMed (R) , an independent specialty pharmacy, has been selected as a pharmacy partner by Cytokinetics for MYQORZO (TM) (aficamten), indicated ...
Those battling chronic illness know what a long, difficult battle it is to get well again, understanding all too well that ...
Those battling chronic illness know what a long, difficult battle it is to get well again, understanding all too well that ...
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
Parade on MSN
This is the #1 New Year’s resolution cardiologists make every year—and how they stick to it
When making New Year's resolutions, cardiologists focus on the "three Ms," which they aim to incorporate into their lives ...
Medical science can typically provide a clear explanation of the intricacies of the human body. However, there are times when ...
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...
Kotlolo’s work addresses a long-standing gap in paediatric HIV treatment, aiming to improve accessibility, ease of ...
A personalized 3-month resistance exercise program improved walking distance and HRQOL in adults with persistent COVID-19 symptoms.
Preliminary total global full year 2025 revenue of approximately $616 million Preliminary BRIUMVI U.S. fourth quarter and full year 2025 net product revenue of approximately $182 million and $594 ...
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...
The Healthy @Reader's Digest on MSN
People whose toes can do this one thing might actually live longer, says a foot researcher
"Almost no footwear" today supports it, says this gait specialist, who explains the aha! connection between the feet and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results